What is the main business of Polfarmex Biotechnologie?

The main business activity of Polfarmex Biotechnologie focuses on research and experimental development on biotechnology.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on November 20, 2014.

Where is the headquarters located?

The headquarters is located at: Józefów 9, 99-300 Kutno.

Who is on the management board?

The management board consists of: Marek Piotr Wośko (President of the Management Board).

What is the share capital?

The share capital of the company is PLN 100,000 (approx. $27,012).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.

What revenue was generated?

The company reported a revenue of $4,010 in 2024, which is an increase of 60.0% compared to 2023.

Is the company profitable?

Yes, in 2024 the company was profitable, achieving a net profit of $941.

Which cost dominates operating expenses?

The largest operating cost category falls under external services. This category amounted to $1,931 in 2024, representing 63% of all operating expenses.

Polfarmex Biotechnologiesp. z o.o.

Research and experimental development on biotechnology

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2014-11-20

Share capital

100,000.00 PLN

Registered address

Józefów 9, 99-300 Kutno, Poland

Branches

Poleczki 35, 02-822 Warszawa

Website

polfarmex.pl

Phone

Social media

Electronic delivery address

AE:PL-74606-34688-GGJAW-26

Financials

Revenue history

Filing timeliness

1 of 6 financial statements was filed late (for 2020, 125 days late).

202506/07/2026
202411/07/2025
202308/07/2024
202223/05/2023
202129/03/2022
202017/02/2022

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue

This companyUSD 3.01kMedianUSD 55.24kAverageUSD 2.71m

Net profit

This companyUSD -523.60MedianUSD -1.27kAverageUSD -91.85k

Operating costs

This companyUSD 3.54kMedianUSD 65.85kAverageUSD 2.66m

Assets

This companyUSD 2.58kMedianUSD 133.19kAverageUSD 3.03m

News

2025-07-22

Employee Safety as an Investment by Polfarmex

2024-06-20

5000 PLN from Polfarmex for Research on Compounds with Anticancer Properties

2023-11-11

Polfarmex Rises in Prestigious Ranking

Industry

Offer

Prescription medicines
Over-the-counter medicines
Dietary supplements
Drug research and development
Biological medicines
Laboratory testing

Certifications: GMP

Website technology

Website

WordPress

Authorized Representatives

Marek Piotr Wośko – President of the Management Board

Manner of representation

If the management board is a multi-member management board, declarations of will and signing on behalf of the company require the joint action of two members of the management board, or one member of the management board jointly with a commercial proxy.

Ownership

Owner	Shares	Share value	Stake
Agnieszka Katarzyna Erlachage 65	1,900	$4,276.97	8.3333%
Halina Regina Wośkoage 89	1,900	$17,107.87	33.3333%
Marek Piotr Wośkoage 61	1,900	$4,276.97	8.3333%
Mieczysław Wośkoage 90	1,900	$25,661.80	50%

Mieczysław Wośko, Halina Regina Wośko and Marek Piotr Wośko hold a combined 91.7% – the ownership structure indicates family control.

Beneficial owners

Person	Rights

Bank accounts

Registered as a VAT taxpayer on 2014-12-08.

BNP Paribas Bank Polska
94 1750 1093 0000 0000 2654 9547

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name	Revenue	Website
Oncotherics PolandS.A.	$7,565.33	oncotherics.com
GenomtecS.A.	$5,273.73	genomtec.com
Fusiomicasp. z o.o.	$5,263.98	fusiomica.com
Astrofoodssp. z o.o.	$3,665.32	astrofarms.space
Spinbionicsp. z o.o.	$3,516.36	spinbionic.com
Omnisepticasp. z o.o.	$3,475.29	omniseptica.com
Poliwatersp. z o.o.	$3,341.79	poliwater.pl
Greenetoxsp. z o.o.	$3,013.95	greenetox.com
Refolditsp. z o.o.	$2,586.64	refoldit.com
Dairy Biotechnologiessp. z o.o.	$1,485.09	milcu.eu

Change history

Date	Event
2020-05-27	Share capital increase (50,000.00 PLN → 100,000.00 PLN)
2015-09-18	PKD change (Removed: 11 codes)
2015-07-10	Share capital increase (5,000.00 PLN → 50,000.00 PLN)
2014-11-20	Entered in the register

FAQ

Last updated: 2026-07-09